Skip to main content
. 2015 Sep 12;5(1):13–22. doi: 10.15171/ijhpm.2015.166

Table 3. Financial Data (2011) .

Costs BE ENG FR GE NL SC SWE SWI
Total healthcare costs as % GDP 10.5 9.4 11.6 11.3 11.9 9.4 9.5 11.0
Curative sector as % GDPa 7.7 - 9.1 8.6 7.4 - 7.7 8.1
Curative sector ($ PPP)a 2978 - 3230 3421 3171 - 3181 4155
Prescription drugs (% healthcare) 15.5 11.4 15.6 14.1 9.4 11.4 12.1 9.4
Per capita prescription drugs (€) 630 374 641 632 479 374 474 530
Financing of curative sectorb
% Collective (government, social security) 71.1 82.8 76.8 77.7 78.5c 82.8 80.5 64.9
% Private (OUPd, private insurance, other) 28.9 17.2 23.3 22.3 21.5c 17.2 19.5 35.1
% Private OUPd 25.0 9.9 9.6 11.7 11.9c 9.9 19.5 25.5

Abbreviations: NL, the Netherlands; BE, Belgium; GE, Germany; ENG, England; FR, France; SC, Scotland; SWE, Sweden; SWI, Switzerland; GDP, gross domestic product; PPP, purchasing power parity; OUP, out-of-pocket.

a We defined ‘curative care’ as a combination of the Organization of Economic Cooperation and Development (OECD) health database categories: Services of curative and rehabilitative care, medical goods and ancillary services to healthcare.

b The OECD database did not allow a breakdown in financing for curative care for England and Scotland (both United Kingdom), thus the data represents financing for a broader range of services (including long-term care and public health).

c The data for the Netherlands has been corrected because the deductibles in the OECD data did not impute as private financing.

d Following the OECD definition, out-of-pocket expenditure includes direct payments for care without insurance benefit, co-payments, co-insurance, and deductibles.

Source: OECD health data for 2011.31